- Stocks
- Cement & Materials
- Arvee Laboratories (India)
Arvee Laboratories (India) share price
NSE: ARVEECement & MaterialsSpecialty Chemicals
Arvee Laboratories (India) at a glance
Arvee Laboratories (India) (NSE: ARVEE) closed at ₹199.29 on 22 Oct 2026, down 2.45% on the day. With a market capitalisation of ₹220 Cr, it ranks 2210th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Cement & Materials sector; its industry is Specialty Chemicals.
At its last close the stock traded at 106× trailing earnings, against a return on equity of 6.9% in FY25. Over the past year the share price has risen 23.0%. Its 52-week range is ₹129.11 (30 Mar 2026) to ₹290.78 (19 Dec 2025); the last close is 31.5% below the high. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹11 Cr (+67.4% year on year) and net profit ₹1 Cr (+642.9%), on a standalone basis. Promoters held 73.50% of the company as of 30 Jun 2026.
Key numbers
- Market cap
- ₹220 CrRank 2210 on NSE
- P/E (trailing)
- 106×
- Price to book
- 5.01×FY25
- EPS (TTM)
- ₹2.29to Q4 FY26
- ROE
- 6.9%FY25
- ROCE
- 9.2%FY25
- Debt to equity
- 0.03FY25
- Net profit margin
- 5.6%FY25
- Book value / share
- ₹28.37FY25
- 52-week high
- ₹290.7819 Dec 2025
- 52-week low
- ₹129.1130 Mar 2026
- 1-year return
- +23.0%
- RSI (14-day)
- 47.2
Returns to 22 Oct 2026
| Period | 1 day | 1 week | 1 month | 3 months | 1 year |
|---|---|---|---|---|---|
| Price change | −2.45% | −7.8% | −4.6% | +28.6% | +23.0% |
Arvee Laboratories (India) quarterly results
| Quarter | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹11 Cr | ₹13 Cr | ₹9 Cr | ₹6 Cr | ₹7 Cr | ₹3 Cr | ₹10 Cr | ₹11 Cr |
| Revenue YoY | +39.5% | +40.6% | +15.7% | +5.0% | −29.4% | −72.5% | +9.8% | +67.4% |
| Net profit | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹2 Cr | ₹1 Cr |
| Net profit YoY | +91.8% | +366.7% | −37.5% | −41.7% | −81.9% | −99.0% | +1,120.0% | +642.9% |
| Net margin | 8.9% | 7.8% | 1.7% | 1.1% | 2.3% | 0.3% | 18.7% | 4.8% |
| EPS | ₹0.85 | ₹0.89 | ₹0.14 | ₹0.06 | ₹0.15 | ₹0.01 | ₹1.66 | ₹0.47 |
Arvee Laboratories (India) financials
| Item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Revenue | ₹45 Cr | ₹47 Cr | ₹40 Cr | ₹61 Cr | ₹30 Cr | ₹38 Cr |
| Operating profit | ₹3 Cr | ₹4 Cr | ₹3 Cr | ₹6 Cr | ₹2 Cr | ₹3 Cr |
| Net profit | ₹2 Cr | ₹3 Cr | ₹3 Cr | ₹4 Cr | ₹1 Cr | ₹2 Cr |
| EPS (₹) | ₹4.04 | ₹2.43 | ₹2.34 | ₹3.74 | ₹0.95 | ₹1.95 |
| Cash from operations | ₹10 Cr | ₹2 Cr | ₹4 Cr | ₹3 Cr | ₹4 Cr | −₹0 Cr |
| Total debt | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
| Shareholders' equity | ₹19 Cr | ₹21 Cr | ₹24 Cr | ₹28 Cr | ₹29 Cr | ₹31 Cr |
Arvee Laboratories (India) shareholding pattern
| Holder | 31 Mar 2026 | 30 Jun 2026 |
|---|---|---|
| Promoters | 73.50% | 73.50% |
| Non-institutions | 26.50% | 26.50% |
Arvee Laboratories (India) vs peers
The listed Cement & Materials companies nearest to Arvee Laboratories (India) by market capitalisation.
| Company | Price | 1 day | 1 year | Market cap | P/E | ROE |
|---|---|---|---|---|---|---|
| CHEMBONDChembond Material Technologies | ₹175.64 | −3.49% | +8.0% | ₹236 Cr | 18.3 | — |
| SIKKOSikko Industries | ₹5.19 | −4.95% | +9.7% | ₹227 Cr | 43.3 | — |
| MULTIBASEMultibase India | — | — | — | ₹225 Cr | — | — |
| INDAGIndag Rubber | — | — | — | ₹223 Cr | — | — |
| ARVEEArvee Laboratories (India) | ₹199.29 | −2.45% | +23.0% | ₹220 Cr | 106 | — |
| SVJS V J Enterpris | — | — | — | ₹219 Cr | — | — |
| GOURMETGourmet Gateway | — | — | — | ₹214 Cr | — | — |
Ask anything about Arvee Laboratories (India)
Pivot answers on the live chart with evidence you can check, and tests strategies against ARVEE's own history. Try: “Why has ARVEE moved over the last three months?” · “Backtest a 50-day moving-average crossover on ARVEE over five years” · “Compare ARVEE with CHEMBOND on margins and valuation”
Frequently asked questions about Arvee Laboratories (India)
What is the share price of Arvee Laboratories (India) today?
Arvee Laboratories (India) (NSE: ARVEE) last closed at ₹199.29 on 22 Oct 2026. Its 52-week high is ₹290.78 and its 52-week low is ₹129.11.
What is the market cap of Arvee Laboratories (India)?
Arvee Laboratories (India)'s market capitalisation is ₹220 Cr (₹220 Cr) at the 22 Oct 2026 close, ranking 2210th among the NSE companies Pivot tracks.
What is the P/E ratio of Arvee Laboratories (India)?
Arvee Laboratories (India) trades at a trailing P/E of 106.
What is the ROE and ROCE of Arvee Laboratories (India)?
Return on equity was 6.9% in FY25 and return on capital employed was 9.2% in FY25 (standalone figures).
Is Arvee Laboratories (India) a debt-free company?
Arvee Laboratories (India) is close to debt-free: its debt-to-equity ratio was 0.03 in FY25.
What were Arvee Laboratories (India)'s latest quarterly results?
For Q4 FY26 (quarter ended 31 Mar 2026), Arvee Laboratories (India) reported revenue of ₹11 Cr, +67.4% year on year, and net profit of ₹1 Cr, +642.9% year on year.
How has Arvee Laboratories (India) stock performed over the last year?
Arvee Laboratories (India)'s share price has risen 23.0% over the past year, +28.6% over three months and −4.6% over one month, to the 22 Oct 2026 close.
What is the shareholding pattern of Arvee Laboratories (India)?
As of 30 Jun 2026: promoters 73.50%, non-institutions 26.50%.
Who are Arvee Laboratories (India)'s competitors?
The listed Cement & Materials companies closest to Arvee Laboratories (India) by market cap are Chembond Material Technologies, Sikko Industries, Multibase India, Indag Rubber, S V J Enterpris and Gourmet Gateway.
Is Arvee Laboratories (India) a good stock to buy?
Pivot does not give buy or sell recommendations. This page sets out Arvee Laboratories (India)'s price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on ARVEE against its own history before risking money. This is analysis, not financial advice.
Sources and method
Prices: NSE daily closes to 22 Oct 2026 (returns and ratios at the 22 Oct 2026 close). Fundamentals: company filings via Moneycontrol, standalone where available. Shareholding: exchange shareholding-pattern filings. The 52-week range uses intraday highs and lows; the chart marks closing prices. P/E is the last close over trailing twelve-month EPS. Market-cap rank is among the 4,183 NSE companies Pivot tracks; SEBI's bands call the top 100 large-cap and the next 150 mid-cap. Figures marked “—” are not available rather than zero. This is analysis, not financial advice.
More: all Cement & Materials stocks · companies starting with A · all NSE stocks · this page as text